Kabonib 60mg Tablet

About Kabonib 60mg Tablet

Kabonib 60mg Tablet contains Cabozantinib, an oral medication used primarily for the treatment of certain types of cancer, including medullary thyroid cancer and renal cell carcinoma. Targeting multiple receptor tyrosine kinases implicated in tumor development, angiogenesis, and metastasis, cabotinib is a multi-tyrosine kinase inhibitor.

This medication should be taken orally with a glass of water, either with or without food; if it causes stomach distress, take it with food.

Brand Name: Kabonib

Composition: Cabozantinib

Mechanism of Action:

Numerous tyrosine kinases, including as MET, VEGFR, and AXL, which are essential for the growth, survival, and blood vessel development of cancer cells, are inhibited by cabotinib. Cabozantinib aids in reducing the growth and spread of tumors by blocking these mechanisms.

Uses:

• Medullary Thyroid Cancer
• Renal Cell Carcinoma

Dosage and Administration:

For renal cell carcinoma and medullary thyroid cancer, the usual initial dosage is 60 mg once daily and 140 mg once daily, respectively. Depending on the patient's condition and reaction to treatment, the precise dosage may change. Cabozantinib should be taken orally, with or without food, at the same time every day. It is best to swallow tablets whole rather than chewing or crushing them.

Side Effects:

         Rash

         Hypertension

         Diarrhea

         Fatigue

         Nausea

         Vomiting

         Shortness of breath

         Bone pain

         Hand foot syndrome

         Loss of appetite

         Dry skin

         Cough